Skip to Content
Merck
All Photos(4)

Key Documents

View All Documentation

B0375

Sigma-Aldrich

Barbital

Synonym(s):

5,5-Diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione, 5,5-Diethylbarbituric acid, Barbitone, Veronal

Sign Into View Organizational & Contract Pricing
All Photos(4)

About This Item

Empirical Formula (Hill Notation):
C8H12N2O3
CAS Number:
57-44-3
Molecular Weight:
184.19
Beilstein:
163999
EC Number:
200-331-2
MDL number:
MFCD00036212
UNSPSC Code:
51361926
PubChem Substance ID:
24891513
NACRES:
NA.21

form

powder

Quality Level

200

drug control

USDEA Schedule IV; Home Office Schedule 3; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

SMILES string

CCC1(CC)C(=O)NC(=O)NC1=O

InChI

1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)

InChI key

FTOAOBMCPZCFFF-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

<ul>
<li><strong>Synthesis and characterization of some pyrimidine, purine, amino acid and mixed ligand complexes: </strong> This study explores the use of Barbital in the synthesis of various ligand complexes, highlighting its application in the development of life science reagents and pharmaceutical intermediates. This could inform R and D strategies for pharmaceutical manufacturing using Barbital as a key intermediate (Masoud et al., 2008).</li>
</ul>

Biochem/physiol Actions

Sedative/hypnotic

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302

Precautionary Statements

P301 + P312 + P330

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
SLCL9110
SLCK8770
SLCK5958
SLCH4870
SLBZ7192

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Haixiang Zhao et al.
Analytica chimica acta, 586(1-2), 399-406 (2007-03-28)
A new method was developed for the rapid screening and confirmation analysis of barbital, amobarbital and phenobarbital residues in pork by gas chromatography-tandem mass spectrometry (GC/MS/MS) with ion trap MSD. The residual barbiturates in pork were extracted by ultrasonic extraction
Mamdouh S Masoud et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 69(1), 230-238 (2007-05-25)
Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes of barbital, thiouracil, adenine, amino acids (methionine, lysine and alanine) and some mixed ligands were prepared and characterized by elemental analyses, IR, electronic spectra, magnetic susceptibility and ESR spectra. Coordination of
Meiling Wang et al.
Journal of chromatography. A, 1217(17), 2821-2831 (2010-03-17)
This work describes a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for multiplex screening, ultratrace quantification and reliable confirmation of barbital series residues in animal-derived food matrices. The method is developed based on a distinct dependency of the electrospray ionization (ESI)
J M Bossert et al.
Behavioural pharmacology, 14(7), 517-523 (2003-10-15)
We have shown previously that 15 mg/kg pentobarbital induces a conditioned place preference (CPP), but it is unsuitable for intracranial administration. Since the long-acting barbiturate, sodium barbital, is soluble at a neutral pH, we tested whether it would induce a
Marlies Oostendorp et al.
Transfusion, 55(6 Pt 2), 1555-1562 (2015-05-20)
Monoclonal antibodies (MoAbs) are increasingly integrated in the standard of care. The notion that therapeutic MoAbs can interfere with clinical laboratory tests is an emerging concern that requires immediate recognition and the development of appropriate solutions. Here, we describe that
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service